SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-006555
Filing Date
2020-05-06
Accepted
2020-05-06 10:29:01
Documents
4
Period of Report
2020-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trov8-k050620.htm 8-K 34655
2 EXHIBIT 3.1 trov050620ex31.htm EX-3.1 7954
3 EXHIBIT 99.1 trovpr050620.htm EX-99.1 21280
4 trovpr050620image1.gif GRAPHIC 9586
  Complete submission text file 0001628280-20-006555.txt   78841
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Trovagene, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 20851560
SIC: 2836 Biological Products, (No Diagnostic Substances)